Literature DB >> 32008809

Feasibility and acceptability of active for life with COPD, an intervention to increase light physical activity in people with COPD.

Janet L Larson1, Katelyn E Webster2.   

Abstract

BACKGROUND: People with chronic obstructive pulmonary disease (COPD) are very sedentary; increasing light physical activity (LPA) may help to promote long-term maintenance of physical activity.
OBJECTIVES: We evaluated feasibility and acceptability of Active for Life with COPD, a self-efficacy-enhancing intervention designed to increase LPA.
METHODS: The 10-week intervention included walking, functional circuit training, and behavioral and educational strategies. Measures included attrition, adherence, objectively measured physical activity, and qualitative interviews.
RESULTS: Thirty-six subjects enrolled in the study; 26 completed the intervention and 19 completed the two-month follow-up. Subjects reported the intervention was enjoyable and beneficial, but disliked the activity log and buddy system. Subjects increased mean time spent standing/stepping by 36 (SD = 82) min/24 h (P > 0.05); they retained a gain of 21 (SD = 88) min/24 h at the two-month follow-up (P > 0.05).
CONCLUSIONS: The Active for Life with COPD intervention is feasible, acceptable, and may support long term maintenance of physical activity.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  COPD; Light physical activity; Sedentary behavior; Self-efficacy

Mesh:

Year:  2020        PMID: 32008809      PMCID: PMC7278526          DOI: 10.1016/j.hrtlng.2020.01.002

Source DB:  PubMed          Journal:  Heart Lung        ISSN: 0147-9563            Impact factor:   2.210


  47 in total

1.  Prognostic value of the objective measurement of daily physical activity in patients with COPD.

Authors:  Francisco Garcia-Rio; Blas Rojo; Raquel Casitas; Vanesa Lores; Rosario Madero; David Romero; Raúl Galera; Carlos Villasante
Journal:  Chest       Date:  2012-08       Impact factor: 9.410

2.  Frailty in people with COPD, using the National Health and Nutrition Evaluation Survey dataset (2003-2006).

Authors:  Soo Kyung Park; Caroline R Richardson; Robert G Holleman; Janet L Larson
Journal:  Heart Lung       Date:  2013-03-25       Impact factor: 2.210

3.  Changes in physical activity and all-cause mortality in COPD.

Authors:  Anouk W Vaes; Judith Garcia-Aymerich; Jacob L Marott; Marta Benet; Miriam T J Groenen; Peter Schnohr; Frits M E Franssen; Jørgen Vestbo; Emiel F M Wouters; Peter Lange; Martijn A Spruit
Journal:  Eur Respir J       Date:  2014-07-25       Impact factor: 16.671

4.  Activity monitors can detect brisk walking in patients with chronic obstructive pulmonary disease.

Authors:  S Singh; M D Morgan
Journal:  J Cardiopulm Rehabil       Date:  2001 May-Jun       Impact factor: 2.081

Review 5.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

Review 6.  Does exercise training change physical activity in people with COPD? A systematic review and meta-analysis.

Authors:  Li Whye Cindy Ng; Jenny Mackney; Sue Jenkins; Kylie Hill
Journal:  Chron Respir Dis       Date:  2011-12-22       Impact factor: 2.444

Review 7.  Level of daily physical activity in individuals with COPD compared with healthy controls.

Authors:  Sigrid N W Vorrink; Helianthe S M Kort; Thierry Troosters; Jan-Willem J Lammers
Journal:  Respir Res       Date:  2011-03-22

8.  Risk factors of readmission to hospital for a COPD exacerbation: a prospective study.

Authors:  J Garcia-Aymerich; E Farrero; M A Félez; J Izquierdo; R M Marrades; J M Antó
Journal:  Thorax       Date:  2003-02       Impact factor: 9.139

9.  The 6-Minute-Walk Distance Test as a Chronic Obstructive Pulmonary Disease Stratification Tool. Insights from the COPD Biomarker Qualification Consortium.

Authors:  Bartolome Celli; Kay Tetzlaff; Gerard Criner; Michael I Polkey; Frank Sciurba; Richard Casaburi; Ruth Tal-Singer; Ariane Kawata; Debora Merrill; Stephen Rennard
Journal:  Am J Respir Crit Care Med       Date:  2016-12-15       Impact factor: 21.405

10.  An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation.

Authors:  Martijn A Spruit; Sally J Singh; Chris Garvey; Richard ZuWallack; Linda Nici; Carolyn Rochester; Kylie Hill; Anne E Holland; Suzanne C Lareau; William D-C Man; Fabio Pitta; Louise Sewell; Jonathan Raskin; Jean Bourbeau; Rebecca Crouch; Frits M E Franssen; Richard Casaburi; Jan H Vercoulen; Ioannis Vogiatzis; Rik Gosselink; Enrico M Clini; Tanja W Effing; François Maltais; Job van der Palen; Thierry Troosters; Daisy J A Janssen; Eileen Collins; Judith Garcia-Aymerich; Dina Brooks; Bonnie F Fahy; Milo A Puhan; Martine Hoogendoorn; Rachel Garrod; Annemie M W J Schols; Brian Carlin; Roberto Benzo; Paula Meek; Mike Morgan; Maureen P M H Rutten-van Mölken; Andrew L Ries; Barry Make; Roger S Goldstein; Claire A Dowson; Jan L Brozek; Claudio F Donner; Emiel F M Wouters
Journal:  Am J Respir Crit Care Med       Date:  2013-10-15       Impact factor: 21.405

View more
  2 in total

1.  Physical Functioning in Patients with Chronic Obstructive Pulmonary Disease Treated with Tiotropium/Olodaterol Respimat in Routine Clinical Practice in Italy.

Authors:  Mauro Carone; Alfio Pennisi; Mariella D'Amato; Alfeo Fiore Donati; Alberto Ricci; Carla Scognamillo; Li Chun; Maria Aliani; Valeria Ronsivalle; Girolamo Pelaia
Journal:  Pulm Ther       Date:  2020-06-18

Review 2.  Physical activity and chronic obstructive pulmonary disease: a scoping review.

Authors:  Xinyue Xiang; Lihua Huang; Yong Fang; Shasha Cai; Mingyue Zhang
Journal:  BMC Pulm Med       Date:  2022-08-05       Impact factor: 3.320

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.